Watts Ryan J. 4
4 · Denali Therapeutics Inc. · Filed Jan 8, 2026
Insider Transaction Report
Form 4
Watts Ryan J.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2026-01-06$16.50/sh−35,198$580,767→ 296,833 total
Holdings
- 2,152,604(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.
- [F2]Includes 184,915 Unvested RSUs.
- [F3]The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.